Kayvan Niazi,Shahrooz Rabizadeh,Justin Golovato,Patrick Soon-Shiong,Anne-Laure Le Ny,Oleksandr Buzko
申请号：
US15264947
公开号：
US20170128568A1
申请日:
2016.09.14
申请国别(地区):
US
年份:
2017
代理人:
摘要：
Calcium flux agonists are used to enhance a TLR- or NOD-mediated stimulus and to so increase an immune response of a host and reduce healing time. Preferred calcium flux agonists include Ca2+ ionophores and SERCA inhibitors and are used in synergistic quantities where a ligand to a TLR or NOD receptor is present.
